Meeting
2022 ASCO Annual Meeting
Epigenetic age acceleration in U.S. testicular cancer survivors (TCS).
Authors
Yinan Zheng
Northwestern University, Chicago, IL
Yinan Zheng , Jun Wang , Paul C. Dinh Jr., Katherine L. Nathanson , Benita Weathers , Linda A. Jacobs , David J. Vaughn , Lifang Hou , Lois B. Travis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Germ Cell/Testicular Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5033)
DOI
10.1200/JCO.2022.40.16_suppl.5033
Abstract #
5033
Poster Bd #
217
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Longitudinal assessment of cognitive functioning in testicular germ cell tumor survivors.
First Author: Zuzana Orszaghova
Poster
2023 ASCO Annual Meeting
Long-term outcomes of adolescents and young adults with testicular germ cell tumors: A population-based retrospective matched cohort study.
First Author: Rand Ajaj
Poster
2023 ASCO Annual Meeting
Outcomes of childhood, adolescent, and young adult cancer survivors (CAYACS) with solid organ transplants: A population-based study.
First Author: Sumit Gupta
Poster
2023 ASCO Genitourinary Cancers Symposium
Peripheral blood immune cell profiling in survivors of testicular germ cell tumors.
First Author: Michal Chovanec